Global Health Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Global Health Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 23.8 times by its yearly operating cash. Higher than 85% of Healthcare companies in India.
- Cash Locked Ratio: For every ₹100 of sales, ₹2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹3 from others' credit three years earlier. Less money tied up than 85% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹129Over the last 3 years, every ₹100 of reported profit came with ₹129 of operating cash.
Higher than 59% of Healthcare companies in India.
Self-Funding Ratio
1.0×Over the last 3 years its own operating cash covered its investment spending (capex) 1.0 times.
Lower than 63% of Healthcare companies in India.
Cash Locked Ratio
₹2For every ₹100 of sales, ₹2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹3 from others' credit three years earlier.
Less money tied up than 85% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹14Sales grew 61% in 3 years; of every extra ₹100 of sales, ₹14 became extra profit.
Lower than 58% of Healthcare companies in India.
Asset Productivity Ratio
+61% / +43%In 3 years sales changed by +61% while total assets changed by +43%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
23.8×Debt due within a year is covered 23.8 times by its yearly operating cash.
Higher than 85% of Healthcare companies in India.
Cash Cushion Ratio
−0%Debt, after subtracting cash, equals 0% of its market value (net debt).
Higher than 58% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 71% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 73% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Global Health Limited owes ₹0.33 for every ₹1 it owns. Net profit rose 16% in the year to Mar 2026, and grew 20% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
57.3Investors pay ₹57.3 for every ₹1 of Global Health Limited's yearly profit, higher than 77% of Healthcare companies in India.
P/B ratio
8.04The share price is 8.04 times Global Health Limited's book value per share, higher than 78% of Healthcare companies in India.
Market cap
₹31,844 CrThe total market value of all of Global Health Limited's shares at today's price (share price × number of shares), larger than 84% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹3,962 CrWhat Global Health Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹147.42Net worth divided by the number of shares. The share price of ₹1,185 is 8.0 times this, which is the P/B above.
Return on equity (ROE)
14.0%Global Health Limited earned 14.0% on its shareholders' money over the last year, higher than 56% of Healthcare companies in India.
Owes vs Owns
0.33×Global Health Limited owes ₹0.33 for every ₹1 it owns (low), lower than 62% of Healthcare companies in India.
Dividend yield
0.04%Global Health Limited pays 0.04% of its share price as dividends a year, lower than 98% of dividend-paying Healthcare companies in India.
Revenue growth
+19%Revenue rose 19% in the year to Mar 2026, and grew 17% a year on average over 3 years.
Profit growth
+16%Net profit rose 16% in the year to Mar 2026, and grew 20% a year on average over 3 years.
Profit margin
12.9%Global Health Limited keeps ₹13 of every ₹100 of revenue as net profit.
Cash quality
1.3×Cash from Global Health Limited's business was 1.3× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
9.3×Global Health Limited's operating profit covered its interest costs 9.3 times in the year to Mar 2026.
Cash vs debt
Net debtGlobal Health Limited had ₹84 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Global Health Limited's P/E ratio?
Investors pay ₹57.3 for every ₹1 of Global Health Limited's yearly profit, higher than 77% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Global Health Limited: ₹31,844 Cr ÷ ₹3,962 Cr (31 Mar 2026) = 8.0.
What is Global Health Limited's return on equity?
Global Health Limited earned 14.0% on its shareholders' money over the last year, higher than 56% of Healthcare companies in India.
How much does Global Health Limited owe compared with what it owns?
Global Health Limited owes ₹0.33 for every ₹1 it owns (low), lower than 62% of Healthcare companies in India.
Does Global Health Limited pay a dividend?
Yes. Global Health Limited pays 0.04% of its share price as dividends a year, lower than 98% of dividend-paying Healthcare companies in India.
Is Global Health Limited's revenue growing?
Revenue rose 19% in the year to Mar 2026, and grew 17% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.